Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: April 2010
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Warner Chilcott Co. LLC et al. v. Mylan Pharmaceuticals Inc.1:10-cv-00285; filed April 8, 2010 in the District Court of Delaware • Plaintiffs: Warner Chilcott Co. LLC; Hoffmann-La Roche Inc.• Defendant: Mylan Pharmaceuticals Inc. Infringement…
-
By Sarah Fendrick — In a recent notice in the Federal Register (75 Fed. Reg. 15689), the U.S. Patent and Trademark Office (USPTO) introduced a new procedure for the review of appeal briefs. The new procedure aims to provide more efficient review of appeal briefs and to reduce the pendency of appeals. Under the…
-
April 11-17, 2010 – Advanced Patent Courses (Patent Resources Group) – Bonita Springs, FL April 14, 2010 – "Obviousness Standard for Patents Post-KSR: Strategies to Withstand USPTO Obviousness Rejections and Attacks on Patent Validity" (Strafford) – 1:00 – 2:30 PM (EST) April 19-21, 2010 – Intellectual Property Counsels Committee (IPCC) Spring Conference & Meeting (Biotechnology…
-
The U.S. Court of Appeals for the Federal Circuit will be holding a Judicial Conference entitled "The Federal Circuit: A National Court of Appeals: Approaching 30 Years" on May 20, 2010 in Washington, DC. Topics and speakers at the conference will include: • A Conversation about the Federal Circuit's History – Professor F. Scott Kieff,…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled: "Bio-Similars: The New Litigation Landscape" on Thursday, April 22, 2010 beginning at 2:00 PM (EST). The IPO webinar will provide an overview of the healthcare reform measure that creates a regulatory pathway for generic versions of large-molecule biotech drugs, which bears some resemblance…
-
Congressman Becerra Once Again Tries to Ban Gene Patenting by Statute By Kevin E. Noonan — When last we encountered Congressman Xavier Becerra (D-CA), he was rumored to be headed for a post as U.S. Trade Representative (see "Proponent of Gene Patent Ban to Leave Congress"). That seems to have fallen through, because the…
-
By James DeGiulio — On Apr. 6, 2010, Kylin Therapeutics of West Lafayette, IN announced the issuance of U.S. Patent No. 7,655,787, which broadly covers a number of functionalities for Kylin's lead technology platform, "pRNA," or "packaging RNA." These functionalities include receptor binding, ribozyme activity, and RNA-interference. The main feature of pRNA is its…
-
By Donald Zuhn — Last week, the District Court for the Southern District of New York ruled in favor of the plaintiffs in Association of Molecular Pathology v. U.S. Patent and Trademark Office, finding the claims of several patents directed to the BRCA1 and BRCA2 genes invalid as encompassing non-statutory subject matter (see "Round…
-
By Donald Zuhn — On Sunday, the CBS news program "60 Minutes" examined the issue of gene patenting in a segment entitled "Patented Genes." During the segment, CBS News correspondent Morley Safer interviewed Lisbeth Ceriani and Genae Girard, who were recently diagnosed with breast cancer and who are plaintiffs in the Association of Molecular…
-
By Donald Zuhn — On Friday, the U.S. Patent and Trademark Office published a notice in the Federal Register (75 Fed. Reg. 16750) seeking comments regarding a proposed change in practice that would, according to Office press release, effectively provide a 12‑month extension to the existing 12-month provisional application period. In particular, the Office…
Patent Docs 